These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 10243910)

  • 1. Managing the hospital pharmacy. Interview by Nancy M. Agresta.
    Lantos RL
    Hosp Formul; 1979 Sep; 14(9):839-43. PubMed ID: 10243910
    [No Abstract]   [Full Text] [Related]  

  • 2. The expanding role of pharmacy. Interview by Nancy Agresta.
    Durgin J
    Hosp Formul; 1980 Apr; 15(4):287-90, 293. PubMed ID: 10245911
    [No Abstract]   [Full Text] [Related]  

  • 3. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P&T Committee overview: Brigham and Women's Hospital.
    Shea BF; Churchill WW; Powell SH; Cooley TW; Maguire JH
    Pharm Pract Manag Q; 1998 Jan; 17(4):76-83. PubMed ID: 10174751
    [No Abstract]   [Full Text] [Related]  

  • 5. Filling and refilling practices with diazepam and methyldopa.
    Scrivens JJ; Weber C; Sather M; Geck W
    Hosp Formul; 1979 Sep; 14(9):830-1,834-6,838. PubMed ID: 10243909
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Providing investigational drug data through a hospitalwide computer system.
    Schwartz PA; Vogenberg FR
    Am J Hosp Pharm; 1983 Jan; 40(1):114-5. PubMed ID: 6337481
    [No Abstract]   [Full Text] [Related]  

  • 8. [Create or strengthen the drug committee at a hospital].
    Bruneton C
    Med Trop (Mars); 2006 Dec; 66(6):569-72. PubMed ID: 17286023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving concerns of pharmacy and therapeutics committees.
    Weintraub M
    Hosp Formul; 1980 Jan; 15(1):29-31. PubMed ID: 10244955
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effective management of DUE (drug utilization evaluation) policy through a pharmacy clerkship.
    Julius HC
    Hosp Formul; 1993 Sep; 28(9):789-91. PubMed ID: 10128394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedure for evaluating nonformulary drug orders.
    Jay GT; Quercia RA; Gousse G; Chow MS; Quintiliani R
    Am J Hosp Pharm; 1993 Dec; 50(12):2554-6. PubMed ID: 8122692
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment and operation of an oncology satellite pharmacy.
    Eddlemon JK; Hayman JN; Breland BD
    Am J Hosp Pharm; 1984 Oct; 41(10):2045-8. PubMed ID: 6496493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent antibiotic-use review in a small hospital.
    Kerns MP; Meyer GE
    Am J Hosp Pharm; 1986 Jun; 43(6):1476-8. PubMed ID: 3728483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P & T Committee interview: Establishing and maintaining a dynamic formulary.
    Rostand S; Lazarus H
    Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCMR interview: the way Dick Wittrup sees it.
    Wittrup D
    Health Care Manage Rev; 1976; 1(1):91-104. PubMed ID: 10241301
    [No Abstract]   [Full Text] [Related]  

  • 16. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How proper planning helped us greatly in moving our pharmacy twice.
    Burns D
    Pharm Times; 1980 Aug; 46(8):90-3. PubMed ID: 10248166
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of the education of hospital pharmacy directors.
    Oakley RS; Bradham DD; Kimberlin CL
    Am J Pharm Educ; 1985; 49(3):277-81. PubMed ID: 10274928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences in planning, designing, and moving to a new hospital.
    Loeb AJ
    Hosp Pharm; 1979 Aug; 14(8):441-4, 447, 451-3. PubMed ID: 10243577
    [No Abstract]   [Full Text] [Related]  

  • 20. Hospital restriction policy for newly marketed antimicrobial agents.
    Jeffrey LP; McCloskey WW; Rich DS; Mahoney CD
    Am J Hosp Pharm; 1986 Sep; 43(9):2230-2. PubMed ID: 3766580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.